Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid in rhytidectomy
NCT03970213Phase 4Unknown
- Sponsor
- Glasgold Group Plastic Surgery
- Start
- May 2019
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of tranexamic acid in hemorrhage, ecchymosis and edema, sponsored by Glasgold Group Plastic Surgery. Primary endpoints: Intraoperative bleeding and Postoperative ecchymosis at 9 days. Status: unknown.
02
Drugs
tranexamic acid
03
Conditions
hemorrhageecchymosisedema
Beyond the preview
Go deeper on NCT03970213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03970213.